Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: Pancho Villa who wrote (862)	11/8/1997 7:04:00 PM
From: Pancho Villa	Respond to of 1359

Another stockholder lawsuit. I guess some people think they were cheated. I am glad I wasn't one of them! Pancho Notice of Class Action Interneuron Pharmaceuticals, Inc. NEW YORK--(BUSINESS WIRE)--Nov. 7, 1997--Interneuron Pharmaceuticals, Inc. ("Interneuron" or the "Company")(Symbol:IPIC) was named a defendant in a class action lawsuit filed on Tuesday in the United States District Court for the District of Massachusetts, Civil Action No. 97-12470 REK, on behalf of purchasers of the Company's securities during the period April 21, 1997, through and including September 17, 1997 (the "Class Period"). The Complaint charges Interneuron and its President and Chief Executive Officer with violating Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by artificially inflating Interneuron's stock price during the Class Period through, among other things, misrepresenting the safety and efficacy of its Redux drug and failing to disclose material risks associated with taking Redux. Plaintiff seeks to recover damages on behalf of all class members and is represented by Weiss & Yourman, Stull Stull & Brody, and the Law Offices of Jeffrey S. Abraham, law firms having significant experience and expertise prosecuting class actions on behalf of investors and shareholders in federal and state courts throughout the United States, particularly those involving misrepresentations and omissions. The firms maintain offices in New York City and Weiss & Yourman and Stull Stull & Brody also maintain offices in Los Angeles. The firms have repeatedly been appointed by courts as leading counsel in numerous complex litigations and have recovered hundreds of millions of dollars on behalf of investors. To assure that you will be included in a list of class members, or if you wish to discuss this action, have any questions concerning this notice, or your rights or interests with respect to this matter, or if you have any information you wish to provide to us, please contact Jack I. Zwick by calling toll-free (888) 593-4771, or via Internet electronic mail at wynyc@aol.com or by writing Weiss & Yourman, The French Building, 551 Fifth Avenue, Suite 1600, New York City 10176, Jules Brody by calling toll-free (800) 337-4983, or via Internet electronic mail at ssbny@aol.com or by writing Stull Stull & Brody, 6 East 45th Street, New York City 10017, or Jeffrey S. Abraham by calling (212) 692-0555, or via Internet electronic mail at Jsalaw@aol.com or by writing Law Offices of Jeffrey S. Abraham, The Lincoln Building, 60 East 42nd Street, Suite 4700, New York City 10165. CONTACT: Jack I. Zwick, 888/593-4771 wynyc@aol.com or Jules Brody, 800/337-4983 ssbny@aol.com or Jeffrey S. Abraham, 212/692-0555 Jsalaw@aol.com --------------------------------------------------------------------------------

To: Pancho Villa who wrote (862)	11/8/1997 7:21:00 PM
From: Pancho Villa	Respond to of 1359

From the WSJ. Interesting article about Corning. IMO, IPIC's spinoff of assets is not fiction! Pancho November 8, 1997 Dow Corning's Bankruptcy Woes Could Stall Payouts for Centuries Associated Press BAY CITY, Mich. -- Some women suing Dow Corning Corp. might have to wait 240 years before getting their day in court if the bankruptcy reorganization by the former breast implant manufacturer takes effect, a public policy analyst testified. Women with claims against the company have two bad options under the company's proposed plan: settle and get paid next to nothing, or litigate and wait years to get in court, said Mark Peterson. The Los Angeles legal and public policy analyst testified in bankruptcy court Thursday. According to Dow Corning's estimates, Mr. Peterson said, more than 12,000 claims won't be settled. And assuming one case a week is heard, it would take more than 200 years for the cases to be resolved. "I doubt any claimant will live 240 years," Mr. Peterson told U.S. Bankruptcy Judge Arthur Spector. Dow Corning wants to give women with silicone-gel breast implants a choice between settling a claim for a range from $650 to $250,000 -- depending on the injuries -- or continuing with a lawsuit. Dow Corning would control the number of cases heard each year, and it proposes hearing only 10 cases a year, but that number may change. Barbara Houser, Dow Corning's lead bankruptcy attorney, said Mr. Peterson's testimony is irrelevant and unsuccessfully asked Judge Spector to strike it from the record, but the judge refused. The bankruptcy hearings continue Nov. 17.